PDB42 PATIENT COMPLIANCE TO EXTENDED-RELEASE VERSUS IMMEDIATERELEASE GLIPIZIDE FOR TYPE 2 DIABETES MELLITUS: A SYSTEMATIC REVIEW
نویسندگان
چکیده
منابع مشابه
Pharmacogenomics of glibenclamide in patients with type 2 diabetes mellitus: A systematic review
Introduction: One of the most widely used anti-diabetic drugs is sulfonylureas, which is often used as one of the first-line drugs in the treatment of type 2 diabetes. Due to the effect of the patient's genetic structure on the drug response (personalized medicine), the identification of genetic variations not only reduces the rate of adverse drug reactions but can also predict the effectivenes...
متن کاملCost effectiveness of type 2 diabetes screening: A systematic review
Background: Although studies reported diabetes mellitus screening cost effective, the mass screening for type2 diabetes remains controversial. In this study we reviewed the recently evidence about the cost effectiveness of mass screening systematically. Methods: We reviewed the MEDLINE, Scopus, Web of Science (WOS), and Cochrane library databases by MeSH terms to identify relevan...
متن کاملinsulinoma in a patient with type 2 diabetes mellitus.
insulinoma in a patient with pre-existing diabetes is extremely rare. only a small number of cases have been reported all over the world. we report a case of insulinoma in a patient with type 2 diabetes. a 63-year-old female was diagnosed to have diabetes mellitus six years ago, she was given metformin and sulphonylurea to control her glycemia, she had adequate glycemic control for many years, ...
متن کاملGlipizide extended release vs regular
Metformin helps your body to better use the insulin your pancreas. . Many people find the Extended Release version is more tolerable. Pharmacokinetics and pharmacodynamics of extended-release glipizide GITS compared with immediate-release glipizide in patients with type II diabetes . 2 Answers (question resolved) Posted in: glipizide xl, glipizide, pharmacy, generic Answer: ER or XL means exten...
متن کاملDesign and Development of Sustained Release Swelling Matrix Tablets of Glipizide for Type Ii Diabetes Mellitus
The aim of the present study was to develop a sustained release monolithic system for the low solubile/low dose glipizide, for the treatment of type II diabetes mellitus. The matrices were prepared by dry blending of polymers hydroxy propyl methyl cellulose (HPMC) or erodible Eudragit (ammonio methacrylate copolymers) and other excipients using direct compression method and were characterized u...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Value in Health
سال: 2010
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)72287-7